Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion type Assertion NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_head.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion evidence source_evidence_literature NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion SIO_000772 8603636 NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion wasDerivedFrom befree-20150227 NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.
- NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion wasGeneratedBy ECO_0000203 NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.